Dr. Christel Fenge joined the Sartorius Stedim Biotech group as Vice President of Marketing for Fermentation Technologies. She will be globally responsible for the management of the product portfolio of multi- and single-use bioreactors, which currently represents the most comprehensive range in the industry.

Most recently Christel Fenge held the position as the General Manager of Recipharm Biologics. Previous posts included senior management positions in biopharmaceutical development at AstraZeneca. She started her industrial career in cell culture process development at Pharmacia & Upjohn and in product management at B.Braun Biotech. Christel Fenge received her doctorate in Biochemistry from the University of Hanover, Germany.

"We are extremely pleased to have Dr. Fenge join our organization to strengthen our Fermentation Technology activities, particularly with regard to implementing and supporting our single-use technology approach she will play an essential role," explained Reinhard Vogt, Member of the Board of Sartorius Stedim Biotech. "She brings with her an exceptional experience base of cell culture and protein science, which will further our customer support and technology bases."

For further nformation please visit www.sartorius-stedim.com